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Abstract
Factors influencing apoptosis of vertebrate eggs and early embryos have been studied in cell-free
systems and in intact embryos by analyzing individual apoptotic regulators or caspase activation in
static samples. Described here is a novel method for monitoring caspase activity in living Xenopus
oocytes and early embryos. The approach, utilizing microinjection of a near-infrared caspase
substrate that emits fluorescence only after its proteolytic cleavage by active effector caspases, has
enabled the elucidation of otherwise cryptic aspects of apoptotic regulation. In particular, we
demonstrate that brief caspase activity (ten minutes) is sufficient to cause apoptotic death in this
system. We illustrate a cytochrome c dose threshold in the oocyte, which is lowered by Smac, a
protein that binds thereby neutralizing inhibitor of apoptosis proteins. We show that meiotic
oocytes develop resistance to cytochrome c, and that eventual death of oocytes arrested in meiosis
is caspase-independent. Finally, data acquired through imaging caspase activity in the Xenopus
embryo suggests that apoptosis in very early development is not cell-autonomous. These studies
both validate this assay as a useful tool for apoptosis research and reveal subtleties in the cell
death program during early development. Moreover, this method offers a potentially valuable
screening modality for identifying novel apoptotic regulators.
Introduction
Apoptosis is a form of programmed cell death executed by caspases. These cysteine
proteases exist in the cytosol as zymogens until death stimuli trigger their activation1.
Apoptotic signals can originate from extracellular ligands binding to cell-surface death
receptors (extrinsic pathway) or from internal cues (e.g. DNA damage) inducing
mitochondrial release of cytochrome c (intrinsic pathway)2. In both cases, the resulting
adaptor protein complexes recruit initiator caspases, leading to their dimerization-induced
activation3. Effector caspases are then processed by initiator caspases, greatly enhancing
their enzymatic activity, freeing them to cleave an array of cellular substrates resulting in
cell dismantling4.
Further study of the biochemical intricacies governing apoptotic signaling pathways is
warranted, given that dysregulation of apoptosis contributes to the development of several
important human pathologies, such as cancer and neurodegeneration5. Monitoring caspase
activation is a critical component of studying apoptotic death, and numerous techniques that
measure caspase activity have been developed6. Traditionally these have relied upon
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biochemical analyses of lysates prepared from large numbers of cells. More recently,
fluorescence resonance energy transfer (FRET)-based caspase substrates have been
developed that enable monitoring of caspase activity in mammalian cells7,8. These assays
generally implement cellular expression of a construct encoding two fluorescent proteins
linked by a short peptide containing a caspase cleavage site (e.g., DEVD); caspase activation
in a cell results in separation of the two fluorescent proteins and a consequent change in
fluorescence emission ratios. Although a powerful tool, the strategy relies on treatment of
cell populations with apoptosis-inducing drugs and fluorescence imaging (microscopy or
flow cytometry) over many hours. Moreover, use of such genetically-encoded FRET
indicators to monitor developmental programmed cell deaths would require production of
transgenic animals and robust expression during embryogenesis.
The Xenopus system has traditionally been used as a powerful tool for studying both early
embryonic development and cell cycle control9,10. Given the critical role of apoptosis in
developmental processes and the emerging interplay between cell cycle and cell death
regulators, this system has great potential to aid in the delineation of these crucial
connections. Although extracts prepared from Xenopus eggs develop caspase activity over
time (that can be monitored using a variety of fluorescent and colorimetric indicators in
vitro), these activities reflect the “death” of multiple pooled eggs in aggregate, rather than
the real-time apoptosis of individual cells11. Microinjection of cytochrome c into Xenopus
oocytes has been demonstrated to reliably induce apoptosis, but detection of death has
depended on changes in oocyte morphology (which take hours to occur) or on indirect
markers of caspase activation (e.g., plasma membrane depolarization)12. Unfortunately,
changes in membrane potential are not specific for apoptotic death, lack the sensitivity of the
cell-free system, and cannot be recorded for more than one oocyte at a time. Thus, to date,
there has been no means for directly measuring caspase activity in an intact Xenopus oocyte
or early embryo.
Here we report a novel method based on a near-infrared dye caspase substrate that allows
measurement of caspase activation in real-time in living Xenopus oocytes. By applying this
technique we have studied the kinetics of caspase activation, assessed the role of Inhibitor of
Apoptosis Proteins (IAPs) in determining sensitivity to cytochrome c, compared caspase
activation during different phases of the cell cycle, and imaged caspase activity in the early
Xenopus embryo. These studies have revealed important subtleties in apoptotic regulation
and also suggest the utility of this system as a tool for identifying novel apoptotic regulators.
Results
A near-infrared caspase substrate enables the detection of caspase activity in Xenopus
oocytes
Recently, a near-infrared (NIR) caspase substrate became commercially available from LI-
COR, Inc.13. This IRDye® 800CW/QC-1 CSP-3 substrate (IRDye) emits fluorescence only
after being cleaved by effector caspases at a canonical DEVD cleavage motif, which
separates non-fluorescent quencher and NIR donor dyes, thereby restoring donor signal
(Figure 1a). To determine if the IRDye would be suitable for detecting caspase activity in
intact Xenopus oocytes, we microinjected oocytes with cytochrome c and the IRDye. As
controls, we microinjected either IRDye, cytochrome c, or IRDye and Saccharomyces
cerevisiae cytochrome c (yeast cytochrome c), which is structurally similar to mammalian
cytochrome c but lacks the ability to trigger caspase activation14. The NIR fluorescence of
microinjected (or untreated control) oocytes was imaged and results are shown in Figure 1b.
Signal detected in the 700 nm channel was caused by oocyte autofluorescence (each red spot
represents a single oocyte) while the 800 nm signal resulted from fluorescence of cleaved
IRDye, with intense signal emanating from oocytes co-injected with cytochrome c and the
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IRDye (Figure 1c). These data strongly suggest that this method is well-suited for detecting
caspase activity in intact oocytes. Designating the signal obtained from oocytes co-injected
with yeast cytochrome c and IRDye as background, oocytes co-injected with cytochrome c
and IRDye reliably yielded a 9-fold signal increase above background when imaged 30
minutes to 1 hour after microinjection (Figure 1d). Additionally, this method allows the
fluorescence of each individual oocyte to be measured (Supplemental Figure 1a), such that
the average fluorescence intensity of the oocytes for each treatment can be calculated
(Supplemental Figure 1b).
To demonstrate that the observed oocyte fluorescence truly reflected caspase activation, we
first asked whether the signal could be negated by a caspase inhibitor or induced by factors
that trigger the release of endogenous cytochrome c. Microinjection of the broad-spectrum
caspase inhibitor z-VAD-fmk inhibited the signal while microinjection of tBid, a truncated
form of Bid that induces cytochrome c release from mitochondria15, produced a signal
comparable to that of the microinjected cytochrome c (Figure 2a). Furthermore, expression
of Bok, a multi-domain pro-apoptotic member of the Bcl-2 family implicated in cell death in
the ovary16, triggered apoptosis in oocytes that could be detected by the IRDye signal
(Figure 2b). Additionally, we prepared cell-free lysates from cytochrome c-microinjected
oocytes to confirm the presence of active caspases, which we analyzed using both an in vitro
colorimetric caspase assay (Figure 2c) and immunoblotting of active caspase-3 (Figure 2d).
In aggregate, these data validate microinjection of the IRDye as a robust technique for
imaging caspase activity within intact oocytes.
Caspases are rapidly activated and long-acting, but are required for a limited time to
ensure cell death
The morphological changes that occur during apoptosis in Xenopus oocytes have been
described previously12. In response to microinjected cytochrome c, oocytes initially appear
unchanged, but approximately two hours post-injection they develop mottling of the animal
pole pigment (Figure 3a). Once an oocyte exhibits this characteristic morphological feature
it will invariably die, but it is thought that caspase activation commits the cell to an
apoptotic death prior to any detectable change in morphology4. Caspase activation in
response to cytosolic cytochrome c is thought to be a rapid event17, and indeed, the IRDye-
based in vivo oocyte caspase assay characterized above yielded detectable fluorescence
within five minutes of cytochrome c microinjection (Figure 3b). This IRDye-based signal
was detected for more than twenty-four hours after microinjection, suggesting that the
cleaved IRDye remained stable within the dying cell (Figure 3c). Microinjection of
cytochrome c alone followed by microinjection of the IRDye at various time points resulted
in a fluorescent signal for at least 4.5 hours after exposure to cytochrome c, suggesting that
caspases remain active and capable of cleaving substrates throughout the apoptotic process
(Figure 3d).
In order to evaluate how long caspase activity must be maintained to cause apoptotic death
(i.e., the “point of no return”) we microinjected cytochrome c followed by co-injection of
IRDye and z-VAD-fmk at 10 minute intervals. As shown in Figure 3e, z-VAD-fmk
effectively inhibited caspase activity as detected by quenching of detectable IRDye
fluorescence. Remarkably, cytochrome c-injected oocytes whose caspase activity was
inhibited after 10, 20 or 30 minutes all exhibited apoptotic death, with the time to
development of apoptotic morphology unchanged in the 20 and 30 minute groups and only
slightly delayed in the 10 minute group (Figure 3f). These data suggest that as little as 10
minutes of caspase activity is sufficient to promote cleavage of critical substrates and ensure
death of the oocyte.
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Inhibitor of apoptosis proteins serve as a brake to apoptosis in oocytes
During the course of these studies, we observed the presence of a threshold value for
intracellular cytochrome c concentration, below which caspases did not become active and
oocytes remained healthy; this cytochrome c threshold seems to fall between 50 and 100
nM, (Figure 2d). These data suggested either that there must be a “buffer” preventing
caspase activity in these cells and/or that the oocyte can tolerate a certain degree of caspase
activity. In some systems (e.g., Drosophila), IAPs appear to play a critical role in
determining cell survival/death. In vertebrates, it appears that IAPs play variable cell-type-
specific roles, with a particular importance in setting the apoptotic threshold in
differentiating cells such as maturing neuronal cells, which harbor low levels of Apaf-118.
We hypothesized that IAP proteins might play a heretofore unsuspected role in setting the
apoptotic threshold in the oocyte. To test this, we first confirmed expression of the two IAPs
that have been described in Xenopus, XLX and xXIAP19,20 (data not shown). We then
microinjected oocytes with a sub-threshold dose of cytochrome c and Smac, a protein that
functions as an inhibitor of IAP function21. Based on IRDye fluorescence, Smac addition
substantially lowered the dose of cytochrome c required to induce caspase activation while
heat-inactivated Smac had no effect (Figure 4a). In the presence of Smac, titration of the
cytochrome c concentration to below 25 nM resulted in a failure of caspases to activate,
suggesting the presence of a residual threshold that is IAP-independent (Figure 4b).
Careful analysis of the cytochrome c titration studies revealed that individual oocytes varied
in their response to a peri-threshold dose. For example, in one particular batch of oocytes, 90
nM cytochrome c induced caspase activation in 30% of oocytes, with IRDye fluorescence of
3 apoptotic and 3 living oocytes displayed in Figure 4c. Evaluation of IAP levels in these
two sub-populations was performed with immunoblotting (Figure 4d). However, the striking
differences in IAP quantities do not necessarily reflect differential expression levels because
IAPs are rapidly degraded by active caspases, which are present only in the apoptotic
oocytes. Ideally we would compare sub-populations prior to cytochrome c microinjection,
but unfortunately there is no means for predicting which oocytes will survive and which will
die. As we have previously reported, an endogenous apoptotic program in oocytes, including
mitochondrial cytochrome c release and caspase activation, is manifested when they are
incubated on the bench, at least in part because they exhaust nutrient stockpiles required for
viability22. We have observed that the presence of Smac hastens the induction of apoptosis
in oocytes aged on the bench (data not shown), further supporting the hypothesis that IAP
levels function as a brake to apoptosis in the oocyte.
Meiotic oocytes develop resistance to cytochrome c, and death of oocytes arrested in
meiosis is caspase-independent
Stage VI Xenopus oocytes are arrested in G2 of the cell cycle. Treatment with progesterone
(PG) induces oocyte maturation, which is marked by germinal vesicle breakdown (GVBD)
and high cdc2 activity indicative of re-entry into the cell cycle23. GVBD results in a sharply
demarcated loss of pigment in the animal pole, which, although distinct from apoptotic
morphology, renders visual determination of whether a meiotic oocyte (post-GVBD) is
undergoing apoptotic death challenging (Figure 5a). Using cell-free systems, we and others
have reported that a meiotic state (M-phase) engenders resistance to cytochrome c-induced
caspase activation24,25. A comparison of IRDye fluorescence in immature and mature
(post-GVBD) oocytes microinjected with cytochrome c confirmed that sensitivity to
cytochrome c decreases with maturation (Figure 5b). Approximately 30 minutes after
stimulation with PG but well before GVBD, PG-treated and control oocytes displayed
comparable sensitivity to cytochrome c, demonstrating that PG is not simply disrupting the
IRDye-based assay, and strengthening the notion that resistance develops with entry into M-
phase (Figure 5c). Notably, mature oocytes, arrested in meiosis II, that are not fertilized
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within several hours slowly deteriorate and ultimately die (Figure 5a). To determine if such
death is caspase-mediated (e.g. apoptotic), we evaluated IRDye-based fluorescence over
time in PG-treated oocytes. We observed that even 24 hours after PG treatment, when
oocytes appeared, by morphological criteria, to be dying, there was no indication of caspase
activity based on the absence of IRDye fluorescence (Figure 5d), suggesting that death in
these oocytes proceeds by a process other than classical apoptosis.
Apoptosis is not cell-autonomous in the early Xenopus embryo
We sought to extend our studies beyond the oocyte to determine if we could image caspase
activation in the early embryo and to investigate if there were novel features of the apoptotic
program at early times post-fertilization. Indeed, caspase activity was detected in fertilized
eggs microinjected with IRDye and cytochrome c (Figure 6a). Further, individual
blastomeres within the embryo were visualized, as in Figure 6a, where it was evident that
IRDye fluorescence was present in both blastomeres, as would be expected since
microinjection occurred prior to cell division. In embryos with two blastomeres, we
microinjected a single blastomere with IRDye and cytochrome c, and fluorescence was
detected within half of the embryo, suggesting that the signal and therefore caspase
activation was localized to the microinjected half of the embryo (Figure 6b). Surprisingly,
under these circumstances morphological death occurred not only in the microinjected half
of the embryo but also in the un-injected half, albeit with a slightly delayed time course
(Figure 6c). In order to determine whether the observed death of the un-injected blastomere
involved caspase activity, we microinjected one blastomere with cytochrome c and the other
with IRDye. Caspase-mediated fluorescence was detected in the IRDye-injected side,
suggesting that cytochrome c introduction into one half of the embryo caused caspase
activation on the opposite side (Figure 6d).
One explanation for this phenomenon would be movement of cytochrome c from one
blastomere to the other via cytoplasmic bridges, which have been reported in the early
Xenopus embryo26,27,28. To evaluate whether we could detect the presence of cytoplasmic
bridges, we performed a series of experiments utilizing microinjection of cell cycle-arresting
proteins and fluorescent dyes. Initially we used Mos protein, which has been previously
shown to arrest the development of one half of an embryo when microinjected29, and
confirmed that in our hands we observe arrest of only one side of the embryo (Figure 6e).
Next, we took advantage of two fluorescent dextrans, one approximating the molecular
weight of the IRDye (dextran, AF680 3000 MW) and one roughly the size of cytochrome c
(dextran, AF680 10000 MW). Patterns of fluorescence in microinjected fertilized eggs
versus single blastomeres of 2-cell embryos were readily distinguishable, yielding a diffuse
or partitioned signal, respectively (Figure 7a). We then microinjected embryos at the two-
cell stage, one blastomere receiving cytochrome c and the 3000MW fluorescent dextran, and
the opposite blastomere receiving the IRDye. As shown in Figure 7b, images of a single
embryo illustrate 700 nm channel signal on one side (fluorescent dextran) and 800 nm
channel signal on the other side (fluorescent IRDye), demonstrating that transfer of dyes
either does not occur or is not detectable with this methodology. Finally, we microinjected a
concentrated preparation of an active, non-degradable fragment of Emi2 protein (aa 489–
651 T545,551A), known to inhibit the anaphase promoting complex, inducing a cell-cycle
arrest similar to that of Mos protein30. In the large majority of microinjected embryos we
observed the expected arrest of one half of the embryo, though in roughly one-third of cases
we observed arrest of the entire embryo, which most likely reflects transfer of Emi2 across
cytoplasmic bridges (Figure 7c). Presumably, transfer of injected Mos (Figure 6d) also
occurred but the concentration was too low to induce an arrest on the un-injected side.
Collectively, these data strongly suggest that apoptosis in the early embryo is not cell-
autonomous as it is in later embryogenesis and adulthood, likely due to the presence of
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cytoplasmic linkages between blastomeres that is below detection by fluorescent dye
imaging. These data are consistent with the notion that it is preferable to eliminate the entire
embryo when apoptosis initiates in a single cell at a point in development when the dying
cell represents a significant portion of the embryo.
Discussion
We employed microinjection of an NIR dye caspase substrate to measure caspase activity in
individual, living Xenopus oocytes and early embryos in real-time. This assay provides
quantitation of caspase activity that can be obtained rapidly (and repeatedly over time), and
is easily distinguishable from oocyte maturation-induced GVBD. Relative to the traditional
Xenopus cell-free system, this approach enables evaluation of individual cells, and has the
unique strength of being able to monitor caspase activity and morphological apoptotic death
in oocytes and developing embryos as separable entities (Figure 3e,f; Figures 6 and 7).
The Xenopus oocyte is easily microinjected and NIR imaging can be performed
immediately following exposure to cytosolic cytochrome c. This enables us to address
questions that have been technically impractical, a strength that is illustrated by our studies
probing caspase activation kinetics. These experiments confirm that caspases become
activated extremely rapidly in response to cytochrome c (in under five minutes).
Additionally, we investigated whether continued caspase activity is required to cause
apoptosis. Our data indicate that even short-term activation of caspases (as brief as 10
minutes of exposure to cytosolic cytochrome c) causes an oocyte to die via apoptosis,
suggesting that only caspase substrates cleaved within this timeframe are essential for cell
dismantling. In light of the vast number of identified caspase substrates31,32, and the
uncertainty of precisely how caspase-mediated proteolysis translates into organized cellular
breakdown, this result yields insight into how caspase substrates might be prioritized for
further functional characterization. Very recently, Edgington et al. reported the development
of activity-based fluorescent probes for imaging the kinetics of caspase activation in vivo33.
It would be of considerable interest to compare these reagents to the substrate used here for
their resolution and sensitivity in our single cell analyses.
In addition to the cytochrome c-induced caspase activity described, we also observed
significant fluorescence of embryos microinjected with IRDye alone by nineteen hours after
fertilization (Figure 7d). Sublethal caspase activity has been reported in Xenopus oocytes as
well as in human preimplantation embryos34,35, and we hypothesize that our observations
reflect the accumulation of minimal amounts of active caspases present at any given time
that become significant only in summation. It is unclear whether these minimal amounts of
caspase activity are important for development or are simply an inexorable consequence of
rapid cell division that is tolerated by the embryo. Regardless, this observation prompted us
reflect upon our IAP studies, where we saw that Smac addition, which we believe serves to
neutralize IAPs in the oocyte, decreases the amount of cytochrome c required to activate
caspases. Perhaps the levels of IAPs endowed to an oocyte determine whether an embryo
will be able to limit the amount of caspase activation to within a tolerable range. One
intriguing possibility warranting further investigation is that IAP levels decrease with age,
making older oocytes more prone to apoptotic death following fertilization.
A series of studies performed in Xenopus embryos refer to the presence of cytoplasmic
bridges between daughter cells26,27,28. Our studies in which we microinject cytochrome c
into individual blastomeres and cause entire embryo apoptosis support this idea. It is well
known that checkpoint activation does not occur in embryos until after the mid-blastula
transition36; one important reason for such a delay might be to prevent the triggering of
apoptosis by minor cellular damage during a time when death of an individual blastomere
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would lead to death of the entire embryo. Conversely, in the presence of a cell-damaging
stimulus sufficiently strong to warrant induction of cell death in a single cell, it would likely
be advantageous to rapidly induce death of the entire embryo to avoid significant
developmental anomalies.
Although our experiments with microinjected cytochrome c and Emi2 strongly support the
notion of communicating cytoplasms, we were unable to image this phenomenon using
fluorescent dyes. So although this assay offers a powerful means for detecting caspase
activity within a single cell, it may be that this imaging modality lacks the sensitivity
required to detect a very weak signal when in direct proximity to a very strong one.
Although clearly advantageous for monitoring apoptosis as part of an inquiry into basic
cellular and developmental processes, the technique presented here might also be employed
as a screening modality to identify apoptotic regulators. The 96-well format combined with
the ease of oocyte microinjection make this system poised for either medium-throughput or
secondary screens. Given our previous reports suggesting that an apoptosome-stimulating
therapeutic might be useful in the treatment of breast and brain tumors37,38, it may prove
worthwhile to employ this assay to screen small-molecule libraries for a cytochrome c
mimetic. Moreover, Xenopus oocytes have been used to good effect in screening small pool
cDNA libraries for novel cell cycle regulators39. A similar approach, using the NIR dye as
an apoptotic indicator, may allow identification of novel cell death-regulating proteins.
Materials and Methods
Molecular biology and chemicals
Standard molecular biology techniques were followed. Unless otherwise specified,
chemicals and reagents were from Sigma-Aldrich (St Louis, MO, USA).
Cloning, protein expression, and mRNA synthesis
Cloning, expression and purification of Mos and Emi2 (aa 489–651) T545,551A were as
described40. Xenopus Bok (xBok) was cloned from an EST clone of the NIBB Xenopus
laevis project. Initially xBok cDNA was amplified utilizing with an EcoRI forward primer
(GGA ATT CTA ATG GAG ATG CTA AGA CGA TC), and an XhoI reverse primer (GCT
CGA GTT ACC GCT CAC GGA GGA C). For mRNA production, xBok was first cloned
into the pSP64T vector to contain an N-terminal FLAG tag. For mRNA synthesis, constructs
were digested with SmaI or HindIII, and mRNAs produced using the mMessage mMachine
RNA kit (Ambion, Austin, TX, USA).
Oocyte isolation, maturation and lysate preparation
Stage VI oocytes were prepared from ovaries manually excised from frogs primed with
gonadotropin from pregnant mare serum (PMSG) (Calbiochem, San Diego, CA, USA),
digested with 2.8 U of Liberase (Roche, Basel, Switzerland) in OR-2 buffer (82.5 mM NaCl,
2 mM KCl, 1 mM MgCl2, 5 mM HEPES [pH 7.5]) for 1.5 hours at room temperature,
washed with OR-2 and stored in OR-2 + 10% fetal bovine serum (Invitrogen, Carlsbad, CA,
USA) + 0.2% gentamicin (Invitrogen) at 18°C. To induce maturation, oocytes were treated
with 200 uM progesterone in OR-2. Oocyte lysate was made by crushing oocytes in oocyte
lysis buffer (20 mM HEPES pH 7.5, 20 mM β-glycerophosphate, 15 mM MgCl2, 20 mM
EGTA, and 1 mM PMSF) followed by centrifugation to remove insoluble material. For
Western blot analysis, three oocyte equivalents were loaded per lane. For analysis of caspase
activity, the lysate was diluted 10-fold with PBS, and incubated at 37°C in the presence of
the colorimetric substrate Ac-DEVD-pNA (Biomol, Plymouth Meeting, PA, USA).
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Absorbance was then measured using a Bio-Rad 680 microplate reader (Hercules, CA,
USA) at 410 nm.
Xenopus in vitro fertilization
Testes were manually excised and used to fertilize fresh eggs laid from PMSG-primed frogs
injected with human chorionic gonadotropin. Fertilized eggs were washed with 0.1× MMR
buffer (10× MMR: 1 M NaCl, 20 mM KCl, 10 mM Mg SO4, 25 mM Ca Cl2, 5 mM HEPES
pH 7.8, 0.8 mM EDTA), and then de-jellied following cortical rotation using 2% cysteine
(Sigma).
Microinjection
Oocytes were typically injected with 40 nl solution contained in a capillary needle using a
PV830 pneumatic picopump (WPI, Berlin, Germany). If multiple rounds of injection were
performed in a single cell, the injection volume was modified such that 40 nl was injected in
total. Cytosolic volume of an oocyte was taken to be 1 ml, and used to calculate the final
intracellular concentration of injected reagents. Microinjected reagents include: IRDye®
800CW/QC-1 CSP-3 substrate (LI-COR, Lincoln, NE, USA) at 200–400 nM, cytochrome c
from equine heart or from Saccharomyces cerevisiae, caspase-8-cleaved Bid (tBid)
(Calbiochem) at 167 nM, z-VAD-fmk (Biomol) at 40–70 nM, human Smac protein (gift
from Mohanish Deshmukh, University of North Carolina at Chapel Hill) used at 280 nM,
dextran AlexaFluor680 3000 MW and dextran AlexaFluor 10,000 MW (Invitrogen). For
mRNAs, 20 ng encoding β-globin or FLAG-xBok were injected per oocyte. For embryo
injection, embryos were maintained in a solution of 0.3× MMR buffer containing 4 % Ficoll
400 (w/v); each blastomere was assumed to have a volume of 0.5 ml and was injected with 8
nl solution. All microinjection experiments included at least three oocytes/embryos per
treatment group and each experiment was performed at least two independent times.
Immunoblotting
Antibodies used include: anti-flag (F3165, Sigma), anti-active caspase 3 (9661, Cell
Signaling, Danvers, MA, USA), anti-actin (A1978, Sigma), anti-XLX serum (gift from Jean
Gautier, Columbia University), and anti-xXIAP (gift from Shigeru Yamashita, Toho
University). Alexa Fluor secondary antibodies (Invitrogen) were used with the Odyssey
Infrared Imaging System (LI-COR).
Imaging
Infrared fluorescence in oocytes was imaged using the Odyssey Infrared Imaging system
(LI-COR). Three to five oocytes per well in a black-walled 96-well plate (Corning Costar,
Lowell, MA, USA) were scanned at a focus offset of 3.0 mm, resolution of 84 um, and
intensity settings of 5 in the 700 nm channel and 0.5 in the 800 nm channel. Embryos were
imaged as above except at a resolution of 21 μm and intensity settings of either 5 or 2.5 in
both channels. Analysis of fluorescence (including quantitation) was performed with the
Odyssey software, v2.1 (LI-COR). Quantitation involved obtaining the total signal intensity
for the three to five oocytes per well. Reflected light images of oocytes and embryos were
captured using a Stemi SV6 Stereomicroscope (Carl Zeiss, Thornwood, NY, USA) with an
attached PowerShot A620 digital camera (Canon, Lake Success, NY, USA). Alternatively, a
WolfVision Professional Visualizer (Duluth, GA, USA) was used to capture reflected light
images of some of the embryos.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Fluorescence can be detected in oocytes microinjected with the IRDye and cytochrome
c
(A) Schematic of the LI-COR IRDye® 800CW/QC-1 CSP-3, which contains a non-
fluorescent quencher dye (IRDyeQC-1) conjugated to a donor dye (IRDye800CW) by a
DEVD-containing peptide. Proteolytic cleavage by active effector caspases separates the
dyes, abolishing fluorescence resonance energy transfer (FRET) thereby restoring the donor
dye fluorescence. Adapted with permission from LI-COR® Biosciences, Inc. (B) Oocytes
were injected as indicated and imaged 30 minutes later. yCC, yeast cytochrome c, and CC,
cytochrome c, both injected at 67 nM. (C) Graphical representation of the total quantitated
signal in the 800 nm channel for each collective group of oocytes from B. Signal from
individual oocytes in B can also be measured to calculate the average oocyte fluorescence
(Supplemental Figure 1a and 1b). (D) Total quantitated signal in the 800 nm channel for
each collective group of oocytes was averaged from independent microinjection experiments
(n=21) of IRDye with either yCC or CC and is displayed +/− S.E.M.
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Figure 2. Oocyte fluorescence is due to activation of caspases
(A) Oocytes were injected with the IRDye and either yCC (267 nM), CC (267 nM), CC (267
nM) + z-VAD-fmk (40 nM), or tBid (167 nM) and imaged after 1 hour. Average oocyte
fluorescence is displayed in Supplemental Figure 1c. (B) Left, IRDye and 20 ng of either B-
globin or flag-tagged Xenopus Bok (xBok) mRNA was injected into oocytes, allowed to
express for 5 hours at room temperature and them imaged. Average oocyte fluorescence is
displayed in Supplemental Figure 1d. Right, oocyte lysates immunoblotted with anti-flag
antibody demonstrated xBok expression. (C) Cell-free lysates were prepared from untreated
or CC-injected oocytes, and analyzed for caspase activity over time after the addition of the
colorimetric caspase substrate Ac-DEVD-pNA. (D) Top, oocytes were injected with the
IRDye and increasing doses of CC or yCC and imaged after 1 hour. Bottom, lysates
prepared from these oocytes immunoblotted for active caspase 3.
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Figure 3. Caspases are rapidly activated in response to cytochrome c; caspases remain active for
hours although their activity is only required for 10 minutes to ensure apoptosis
(A) Oocytes were injected with yCC (healthy) or CC (apoptotic) at 106 nM, and
photographed 3 hours later. (B) Oocytes microinjected with IRDye and either yCC or CC at
67 nM were imaged for fluorescence after 5 minutes, demonstrating rapidity of the signal in
response to even small amounts of CC. Average oocyte fluorescence is displayed in
Supplemental Figure 1e. (C) Oocytes microinjected with IRDye and either yCC or CC at
533 nM were imaged after 24 hours, demonstrating a stable, selective induction of signal in
CC-injected oocytes even at high yCC concentrations. Average oocyte fluorescence is
displayed in Supplemental Figure 1f. (D) Oocytes microinjected with either CC or yCC at
80 nM at t=0 were then injected with IRDye at various times indicated, and imaged 30
minutes later. Average oocyte fluorescence is displayed in Supplemental Figure 1g. (E) CC
or yCC was microinjected at 533 nM at t=0, then IRDye and z-VAD-fmk (70 nM) were
injected at times indicated and then imaged 30 minutes later. Note z-VAD-fmk-mediated
signal inhibition even at high concentrations of CC. Average oocyte fluorescence is
displayed in Supplemental Figure 1h. (F) Survival curve based on observation of apoptotic
morphology of oocytes that had been treated as described in E.
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Figure 4. A cytochrome c threshold exists in oocytes and is lowered by Smac addition
(A) Oocytes were microinjected with IRDye and either sub-threshold CC (44 nM), supra-
threshold level of CC (107 nM), 44nM CC plus Smac protein, 44nM yCC plus Smac, or
44nM CC plus Smac that had been heat-inactivated by heating at 95°C for 5 minutes (HI-
Smac) and then imaged after 40 minutes. Smac was injected to a concentration of 280 nM.
Average oocyte fluorescence is displayed in Supplemental Figure 1i. (B) Low doses of CC
were injected with the IRDye and Smac and imaged after 30 minutes. Average oocyte
fluorescence is displayed in Supplemental Figure 1j. (C) Oocytes were injected with IRDye
and increasing doses of CC and imaged after 45 minutes. Naive oocytes from the same batch
were then injected with IRDye and 90nM CC, observed for apoptotic morphology and then
3 apoptotic and 3 living oocytes were imaged for fluorescence. Average oocyte fluorescence
is displayed in Supplemental Figure 1k. (D) Lysates were prepared from the apoptotic and
living oocyte groups described in C and then immunoblotted for XLX.
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Figure 5. Progesterone-induced oocyte maturation decreases sensitivity to cytochrome c
(A) Reflected light images of healthy stage VI oocytes (top left), progesterone-treated
oocytes demonstrating GVBD (top right), cytochrome c-injected apoptotic oocytes (bottom
left), and deteriorating un-fertilized oocytes 20 hours after GVBD (bottom left). (B) Oocytes
were treated with progesterone and allowed to mature until GVBD, approximately 5 hours.
Post-GVBD or control-treated oocytes were then injected with the IRDye and yCC or CC (at
67 nM), and then imaged after 1 hour. Average oocyte fluorescence is displayed in
Supplemental Figure 1l. (C) Oocytes were treated with progesterone for 30 minutes before
injecting them or control-treated oocytes with the IRDye and yCC or CC (at 533 nM), and
imaged after 1 hour. Average oocyte fluorescence is displayed in Supplemental Figure 1m.
(D) Oocytes were treated with progesterone or control, microinjected with IRDye after
GVBD and then imaged for fluorescence 24 hours after progesterone treatment. Oocytes
injected at the same time with IRDye and CC at 67 nM were included as a positive control.
Average oocyte fluorescence is displayed in Supplemental Figure 1n.
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Figure 6. Cytochrome c injection of a single blastomere causes death of the entire embryo
(A) Fertilized eggs were injected prior to the first cell cleavage with the IRDye or IRDye
and CC and then imaged during the 2-cell stage. Autofluorescence is shown in the 700 nm
channel and caspase activity in the 800 nm channel. (B) One blastomere of a two-cell
embryo was microinjected with IRDye and either CC or yCC (at 270 nM)., and imaged after
30 minutes (approximately 3 hours after fertilization). (C) Embryos from B were
photographed 4 hours after fertilization. (D) Embryos were injected as indicated and then
imaged 30 minutes later (approximately 3 hours after fertilization). (E) Photograph of Mos-
arrested embryos, with left half arrested while right half of embryos continue.
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Figure 7. Apoptosis is not cell-autonomous in the early embryo
(A) Fluorescent dextrans were injected as indicated and then embryos were imaged 30
minutes later. (B) One embryo injected as indicated and imaged 30 minutes later. Signal in
the 700 nm channel represent fluorescent dextran and signal in the 800 nm channel
represents IRDye cleavage. (C) Emi2 mutant protein was injected into one blastomere at the
two-cell stage and photographs were taken approximately 4 hours post-fertilization. The
embryo on the left demonstrates full arrest, rather than arrest of only the injected side. (D)
Left, Embryos were injected as indicated (approximately 2 hours post-fertilization) and
imaged for fluorescence at the indicated times after fertilization. Right, photographs of the
embryos 19 hours post-fertilization, confirming IRDye-injected embryos are dividing
normally and show no signs of apoptosis.
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